SG Americas Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,600
Closed -$223K 3780
2019
Q4
$223K Hold
10,600
﹤0.01% 2410
2019
Q3
$76K Hold
10,600
﹤0.01% 2764
2019
Q2
$87K Hold
10,600
﹤0.01% 2833
2019
Q1
$70K Sell
10,600
-51,000
-83% -$7.39M ﹤0.01% 3134
2018
Q4
$59K Buy
+61,600
New +$10.1M ﹤0.01% 2806
2018
Q2
Sell
-12,700
Closed -$59K 3643
2018
Q1
$59K Sell
12,700
-63,200
-83% -$10.6M ﹤0.01% 3056
2017
Q4
$6K Buy
75,900
+15,000
+25% +$2.69M ﹤0.01% 3104
2017
Q3
$50K Sell
60,900
-89,700
-60% -$20.9M ﹤0.01% 3319
2017
Q2
$2.73M Sell
150,600
-12,700
-8% -$2.98M 0.02% 694
2017
Q1
$2.9M Sell
163,300
-220,700
-57% -$51.4M 0.03% 689
2016
Q4
$83K Sell
384,000
-179,700
-32% -$37.2M ﹤0.01% 2896
2016
Q3
$2.17M Buy
563,700
+192,200
+52% +$47M 0.02% 685
2016
Q2
$1.91M Buy
371,500
+62,200
+20% +$14.3M 0.01% 872
2016
Q1
$787K Buy
309,300
+289,600
+1,470% +$82.9M 0.01% 1467
2015
Q4
$75K Buy
+19,700
New +$5.87M ﹤0.01% 2431
2015
Q3
Sell
-14,700
Closed -$169K 2869
2015
Q2
$169K Buy
+14,700
New +$4.38M ﹤0.01% 2062

Other funds holding AGN

SG Americas Securities's AGN Position: Q2 2020 in Review

SG Americas Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 80,536 shares — an estimated $14.3M sold.

SG Americas Securities first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $46.4M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • SG Americas Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • SG Americas Securities sold 80,536 Allergan plc shares in Q2 2020, an estimated $14.3M.
  • SG Americas Securities first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • SG Americas Securities's Allergan plc position peaked at $46.4M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on SG Americas Securities's 13F filing for Q2 2020, filed 20 Jul 2020.